Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Sareena Singh"'
Publikováno v:
Gynecologic Oncology Reports, Vol 22, Iss C, Pp 72-74 (2017)
Background: Malignant ovarian germ cell tumors are rare, and often treatable with surgery and chemotherapy. Few data are available for treatment of platinum-resistant tumors. Case: A 31 year old gravida 0 with a 20 cm pelvic mass was found to have a
Externí odkaz:
https://doaj.org/article/c1eb339b99084b2fb75fc402243e8199
Publikováno v:
Obstetrics and Gynecology International, Vol 2017 (2017)
Background. To determine the prognostic significance of pretreatment levels of circulating lymphocyte (CLC), neutrophil (CNC), and monocyte (CMC) counts in patients with locally advanced cervical carcinoma (CC) treated with definitive radiation. Meth
Externí odkaz:
https://doaj.org/article/69a7c5c59640403399062f03000fae6e
Publikováno v:
Gynecologic Oncology Reports, Vol 13, Iss C, Pp 5-7 (2015)
Externí odkaz:
https://doaj.org/article/a04e901603494defbb081e66ccad625a
Management of Early Stage, High-Risk Endometrial Carcinoma: Preoperative and Surgical Considerations
Publikováno v:
Obstetrics and Gynecology International, Vol 2013 (2013)
Endometrial cancer is the most common gynecologic malignancy in the developed world. Most cases are diagnosed at an early stage and have low-grade histology, portending an overall excellent prognosis. There exists a subgroup of patients with early, h
Externí odkaz:
https://doaj.org/article/f7fd610fcc4641629ae67e4be3cf4c9d
Autor:
Rita A. Avelar, Amy J. Armstrong, Gracie Carvette, Riya Gupta, Noah Puleo, Jose A. Colina, Peronne Joseph, Alexander M. Sobeck, Caitlin M. O'Connor, Brynne Raines, Agharnan Gandhi, Michele L. Dziubinski, Daniel S. Ma, Kimberly Resnick, Sareena Singh, Kristine Zanotti, Christa Nagel, Steven Waggoner, Daffyd G. Thomas, Stephanie L. Skala, Junran Zhang, Goutham Narla, Analisa DiFeo
Publikováno v:
Molecular Cancer Therapeutics. 22:599-615
High-grade serous carcinoma (HGSC) is the most common and lethal ovarian cancer subtype. PARP inhibitors (PARPi) have become the mainstay of HGSC-targeted therapy, given that these tumors are driven by a high degree of genomic instability (GI) and ho
Autor:
Analisa DiFeo, Goutham Narla, Junran Zhang, Stephanie L. Skala, Daffyd G. Thomas, Steven Waggoner, Christa Nagel, Kristine Zanotti, Sareena Singh, Kimberly Resnick, Daniel S. Ma, Michele L. Dziubinski, Agharnan Gandhi, Brynne Raines, Caitlin M. O'Connor, Alexander M. Sobeck, Peronne Joseph, Jose A. Colina, Noah Puleo, Riya Gupta, Gracie Carvette, Amy J. Armstrong, Rita A. Avelar
Fig. S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35fb0df1df4796d0ca534c5991b1c5a9
https://doi.org/10.1158/1535-7163.22758792.v1
https://doi.org/10.1158/1535-7163.22758792.v1
Autor:
Analisa DiFeo, Goutham Narla, Junran Zhang, Stephanie L. Skala, Daffyd G. Thomas, Steven Waggoner, Christa Nagel, Kristine Zanotti, Sareena Singh, Kimberly Resnick, Daniel S. Ma, Michele L. Dziubinski, Agharnan Gandhi, Brynne Raines, Caitlin M. O'Connor, Alexander M. Sobeck, Peronne Joseph, Jose A. Colina, Noah Puleo, Riya Gupta, Gracie Carvette, Amy J. Armstrong, Rita A. Avelar
High-grade serous carcinoma (HGSC) is the most common and lethal ovarian cancer subtype. PARP inhibitors (PARPi) have become the mainstay of HGSC-targeted therapy, given that these tumors are driven by a high degree of genomic instability (GI) and ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26e6f3c08b0a2750fd72bd0b45b54a87
https://doi.org/10.1158/1535-7163.c.6611321.v1
https://doi.org/10.1158/1535-7163.c.6611321.v1
Autor:
Analisa DiFeo, Goutham Narla, Junran Zhang, Stephanie L. Skala, Daffyd G. Thomas, Steven Waggoner, Christa Nagel, Kristine Zanotti, Sareena Singh, Kimberly Resnick, Daniel S. Ma, Michele L. Dziubinski, Agharnan Gandhi, Brynne Raines, Caitlin M. O'Connor, Alexander M. Sobeck, Peronne Joseph, Jose A. Colina, Noah Puleo, Riya Gupta, Gracie Carvette, Amy J. Armstrong, Rita A. Avelar
Table S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f9225af97666e9514aabae0c355fbbc
https://doi.org/10.1158/1535-7163.22674500.v1
https://doi.org/10.1158/1535-7163.22674500.v1
Autor:
Goutham Narla, Analisa DiFeo, Shozeb Haider, Wenqing Xu, Mark W. Jackson, Sareena Singh, Kimberly Resnick, Christa Nagel, Amy J. Armstrong, Kristine Zanotti, Steven Waggoner, Stefanie Avril, Corinne LaVasseur, Jaya Sangodkar, Daniel Leonard, Haichi Song, Guobo Shen, Zhizhi Wang, Caitlin M. O'Connor, Sarah E. Taylor
Supplemental data for the classical and enhanced sampling molecular dynamics simulations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c36e9db9aace1b276888242b34e8d0f3
https://doi.org/10.1158/0008-5472.22422401
https://doi.org/10.1158/0008-5472.22422401
Autor:
Goutham Narla, Analisa DiFeo, Shozeb Haider, Wenqing Xu, Mark W. Jackson, Sareena Singh, Kimberly Resnick, Christa Nagel, Amy J. Armstrong, Kristine Zanotti, Steven Waggoner, Stefanie Avril, Corinne LaVasseur, Jaya Sangodkar, Daniel Leonard, Haichi Song, Guobo Shen, Zhizhi Wang, Caitlin M. O'Connor, Sarah E. Taylor
Somatic mutation of the protein phosphatase 2A (PP2A) Aα-subunit gene PPP2R1A is highly prevalent in high-grade endometrial carcinoma. The structural, molecular, and biological basis by which the most recurrent endometrial carcinoma–specific mutat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a5aa37893cb6bdfabe0bb51338956ba
https://doi.org/10.1158/0008-5472.c.6511205.v1
https://doi.org/10.1158/0008-5472.c.6511205.v1